Concepedia

Denise Sickert

DS

11

Publications

729

Citations

11

H-Index

2003

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Novartis (United States)

Denise Sickert is an author at Novartis (Switzerland) specializing in medicine, immunology, and autoimmunity.

Top concepts

Publications per year

2003–2019

11

Publications

11

Clinical Pharmacology of Tisagenlecleucel in B-cell Acute Lymphoblastic Leukemia

Karen Thudium Mueller, Edward Waldron, Stephan A. Grupp et al. · Clinical Cancer Research · 2018 · 218 citations · Full text

Multiple tumor marker analyses (PSA, hK2, PSCA, trp-p8) in primary prostate cancers using quantitative RT-PCR

Susanne Fuessel, Denise Sickert, Axel Meye et al. · International Journal of Oncology · 2003 · 97 citations

, , +13

Characterization of the in vitro and in vivo properties of CFZ533, a blocking and non-depleting anti-CD40 monoclonal antibody

Jacinda Ristov, Pascal Espié, Peter Ulrich et al. · American Journal of Transplantation · 2018 · 89 citations · Full text

First-in-human clinical trial to assess pharmacokinetics, pharmacodynamics, safety, and tolerability of iscalimab, an anti-CD40 monoclonal antibody

Pascal Espié, Yanling He, Phillip J. Koo et al. · American Journal of Transplantation · 2019 · 81 citations

A Novel, Blocking, Fc-Silent Anti-CD40 Monoclonal Antibody Prolongs Nonhuman Primate Renal Allograft Survival in the Absence of B Cell Depletion

Francisco Córdoba, Grazyna Wieczorek, M. Audet et al. · American Journal of Transplantation · 2015 · 77 citations · Full text

Rows per page

1–5 of 11